REPORT OF A CASE
A 62-year-old white woman with long-standing rosacea began treatment with minocycline hydrochloride, 200 mg/d, in 1990. She presented in February 1996 with perioral and malar blue-black pigmentation (Figure 1). The cumulative dose of minocycline hydrocholoride amounted to 440 g. Minocycline therapy was then discontinued and 4% hydroquinone cream was prescribed to be applied twice daily to the hyperpigmented skin. After a 6month therapeutic trial of hydroquinone, there was no change in the color or extent of hyperpigmentation. At this time, the patient was referred to our center for evaluation.
To effectively treat cosmetically disfiguring facial hyperpigmentation caused by long-term minocycline therapy.
At the time of initial consultation, 2 different test sites on the patient's left upper lip were treated with the Q-switched neodymium:YAG laser (5-nanosecond pulse duration; 3-mm spot size) (Continuum Biomedical, Livermore, Calif). Following skin preparation with chlorhexidine gluconate, the procedure was
Wilde JL, English JC, Finley EM. Minocycline-Induced Hyperpigmentation: Treatment With the Neodymium:YAG Laser. Arch Dermatol. 1997;133(11):1344–1346. doi:10.1001/archderm.1997.03890470014001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: